The second edition of the European Healthtech Investment Forum 2018 will take place on 6-7 March 2018 in Helsinki, bringing together leading investors from Europe and some of the most promising Healthtech entrepreneurs of Europe and Finland. The event will concentrate on the following subsectors:
40 of the best European early stage Healthtech companies will be selected to present at the event by the investors from our selection committee. The applying companies will be assessed on the basis of their business potential, product and technology merit, competitive position, investment or partnering interest, team experience and project quality. The event will once again allow entrepreneurs to meet and present themselves to active international investors and corporations seeking investment and partnerships.
The first edition of the Forum (see last year`s website) gathered an impressive group of Healthtech stakeholders for two days of fruitful activities. Some of the highlights are:
After the first successful edition, the European Healthtech Investment Forum will once again take place in Finland, which is becoming a leading digital health hub with start-ups in the sector, growing at a huge speed. The country has invested in health for decades, supporting companies via various funding programs.
The total amount invested in Finnish early stage companies has grown with 42% in 2016 (383 million euros invested, with 216 M€ of them in direct foreign investments). In total over 400 startups received investments.
(according to the Finnish Business Angels Network (FiBAN) and Finnish Venture Capital Association (FVCA), source here)
Those facts strengthen Finland`s position as an internationally renowned forerunner in health sector research, innovation, investment and new business activities. The European Healthtech Investment Forum with its two-day intensive programme will be the perfect opportunity for participants to deep dive into the dynamic Finnish investment environment.
The European Healthtech Investment Forum is organized in collaboration with: